• 1
    National Institutes of Health Consensus Development. National Institutes of Health Consensus Development Conference statement: neurofibromatosis. Arch Neurol 1988; 45: 5758.
  • 2
    Moore BD III, Denckla MB. Neurofibromatosis. In: Yeates KO, Ris D, Taylor HG, editors. Textbook of Pediatric Neuropsychology: Research, Theory, and Practice, 1st edn. New York, NY: The Guildford Press, 2000: 14970.
  • 3
    Williams VC, Lucas J, Babcock MA, Gutmann DH, Korf B, Maria BL. Neurofibromatosis type 1 revisited. Pediatrics 2009; 123: 12433.
  • 4
    Levine TM, Materek A, Abel J, O’Donnell M, Cutting LE. Cognitive profile of neurofibromatosis type 1. Semin Pediatr Neurol 2006; 13: 820.
  • 5
    Hyman SL, Gill DS, Shores EA, Steinberg A, North KN. T2-hyperintensities in children with neurofibromatosis type 1 and their relationship to cognitive functioning. J Neurol Neurosurg Psychiatry 2007; 78: 108891.
  • 6
    Moore BD III, Slopis JM, Jackson EF, De Winter AE, Leeds NE. Brain volume in children with neurofibromatosis type 1: relation to neuropsychological status. Neurology 2000; 54: 91420.
  • 7
    Steen RG, Taylor JS, Langston JW, et al. Prospective evaluation of the brain in asymptomatic children with neurofibromatosis type 1: relationship of macrocephaly to T1 relaxation changes and structural brain abnormalities. Am J Neuroradiol 2001; 22: 8107.
  • 8
    Van Engelen SJPM., Krab LC, Moll HA, et al. Quantitative differentiation between healthy and disordered brain matter in patients with neurofibromatosis type I using diffusion tensor imaging. Am J Neuroradiol 2008; 29: 81622.
  • 9
    Hyman SL, Shores EA, North KN. Learning disabilities in children with neurofibromatosis type 1: subtypes, cognitive profile, and attention-deficit–hyperactivity disorder. Dev Med Child Neurol 2006; 48: 9737.
  • 10
    Clements-Stephans AM, Rimrodt SL, Gaur P, Cutting LE. Visuospatial processing in children with neurofibromatosis type 1. Neuropsychologia 2008; 46: 6907.
  • 11
    Feldmann R, Denecke J, Grenzebach M, Schuierer G, Weglage J. Neurofibromatosis type 1: motor and cognitive function and T2-weighted MRI hyperintensities. Neurology 2003; 61: 17258.
  • 12
    Ozonoff S. Cognitive impairment in neurofibromatosis type 1. Am J Med Genet 1999; 89: 4552.
  • 13
    Rowbotham I, Pit-ten Cate IM, Sonuga-Barke EJS, Huijbregts SCJ. Cognitive control in adolescents with neurofibromatosis type 1. Neuropsychology 2009; 23: 5060.
  • 14
    Noll RB, Reiter-Purtill J, Moore BD, et al. Social, emotional, and behavioural functioning of children with NF1. Am J Med Genet A 2007; 143: 226173.
  • 15
    Barton B, North K. Social skills of children with neurofibromatosis type 1. Dev Med Child Neurol 2004; 46: 55363.
  • 16
    Mautner VF, Kluwe L, Thakker SD, Leark RA. Treatment of ADHD in neurofibromatosis type I. Dev Med Child Neurol 2002; 44: 16470.
  • 17
    Bechara A, Damasio H, Damasio AR. Emotion, decision making, and the orbitofrontal cortex. Cereb Cortex 2000; 10: 295307.
  • 18
    Beer JS, Shimamura AP, Knight RT. Frontal lobe contributions to executive control of cognitive and social behavior. In: Gazzaniga MS, editor. The Cognitive Neurosciences III, 3rd edn. Cambridge, MA: MIT Press, 2004: 1091104.
  • 19
    Ochsner KN. How thinking controls feeling: a social cognitive neuroscience approach. In: Harmon-Jones E, Winkielman P, editors. Social neuroscience: Integrating Biological and Psychological Explanations of Social Behavior. New York, NY: The Guildford Press, 2007: 10633.
  • 20
    Heberlein AS, Adolphs R. Neurobiology of emotion recognition: current evidence for shared substrates. In: Harmon-Jones E, Winkielman P, editors. Social neuroscience: Integrating Biological and Psychological Explanations of Social Behavior. New York, NY: The Guildford Press, 2007: 3155.
  • 21
    De Sonneville LMJ. Amsterdam neuropsychological tasks: a computer aided assessment programme. In: Den Brinker BPLM, Beek PJ, Brand AN, Maarse FJ, Mulder LJM, editors. Cognitive Ergonomics, Clinical Assessment and Computer Assisted Learning: Computers in Psychology. Lisse, the Netherlands: Swets and Zeitlinger, 1999: 187203.
  • 22
    Huijbregts SCJ, Swaab-Barneveld H, De Sonneville LMJ. Cognitive and motor control in neurofibromatosis type I: Influence of maturation and hyperactivity-inattention. Dev Neuropsychol (Forthcoming).
  • 23
    Herba CM, De Bruin E, Althaus M, Verheij F, Ferdinand RF. Face and emotion recognition in MCDD versus PDD-NOS. J Autism Dev Disord 2008; 38: 70618.
  • 24
    Serra M, Althaus M, De Sonneville LMJ, Stant AD, Jackson AE, Minderaa RB. Face recognition in children with a pervasive developmental disorder not otherwise specified. J Autism Dev Disord 2003; 33: 30317.
  • 25
    De Sonneville LMJ, Verschoor CA, Njiokiktjien C, Op het Veld V, Toorenaar N, Vrancken M. Facial identity and facial emotions: speed, accuracy, and processing strategies in children and adults. J Clin Exp Neuropsychol 2002; 24: 20013.
  • 26
    Yurgelun-Todd D. Emotional and cognitive changes during adolescence. Curr Opin Neurobiol 2007; 17: 2517.